Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis

被引:14
作者
Chen Delong [1 ,2 ]
Wang Haibin [3 ,4 ]
Meng, Zhang [1 ,2 ]
Shan, Jiang [1 ,2 ]
Chi, Zhou [2 ,3 ]
Bin, Fang [2 ,3 ,4 ]
Peng, Chen [2 ,3 ,4 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Med Sch 1, Baiyun Area, 12 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Lab Orthopaed & Traumatol, Chinese Med Lingnan Med Res Ctr, Baiyun Area, 12 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
[3] Guangzhou Univ Chinese Med, Orthoped Dept, Affiliated Hosp 1, Baiyun Area, 16 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
[4] Guangzhou Univ Chinese Med, Hip Ctr, Baiyun Area, 16 Jichang Rd, Guangzhou 510405, Guangdong, Peoples R China
来源
JOURNAL OF BONE ONCOLOGY | 2018年 / 13卷
基金
中国国家自然科学基金;
关键词
LncRNAs; Osteosarcoma; Prognosis; Meta-analysis; POOR-PROGNOSIS; UP-REGULATION; INHIBITS PROLIFERATION; CELL-PROLIFERATION; PROMOTES; PROGRESSION; MIGRATION; INVASION; SURVIVAL; CANCER;
D O I
10.1016/j.jbo.2018.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Numerous studies have reported the relationship between Long non-coding RNAs (LncRNAs) expression and prognosis of osteosarcoma, but less consensus has been reached. Our meta-analysis was conducted to quantitatively assess the relationship between the expression of LncRNAs, prognosis and clinical pathology in osteosarcoma development. Methods: PubMed, Embase, Web of Science, The Cochrane Library, SionMed, CNKI and WanFang databases were carefully searched to identify eligible studies. The pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated to evaluate the prognostic significance of LncRNAs expression in osteosarcoma. Moreover, meta-regression analysis and subgroup analysis were carried out to explore the potential sources of heterogeneity. Results: A total of 20 studies comprising 1749 patients were included in present meta-analysis. The results showed that the over-expression of LncRNA had a significant correlation with overall survival (OS) (HR = 2.16, 95% CI: 1.68-2.79), and was not related to disease free survival (DFS) (HR = 0.71, 95% CI: 0.05-9.53). Subgroup analysis further indicated that LncRNA transcription level was significantly associated with alkaline phosphatase (HR = 2.13, 95% CI: 1.58-2.88), tumor size (< 8/ >= 8: HR = 1.97, 95% CI: 1.55-2.62), metastasis (yes/no: HR = 2.14,95% CI: 1.15-3.97), distant metastasis(presence/absence: HR = 4.02, 95% CI: 3.05-5.23) and Enneking stage(IIA /IIB-III: HR = 3.2, 95% CI: 2.48-4.14), but not associated with age (<= 25/> 25: HR = 1.01, 95% CI: 0.78-1.3), gender(female/male: HR = 1.15, 95% CI: 0.96-1.37), tumor site (femur, tibia/elsewhere: HR = 1.15, 95% CI: 0.94-1.4) and chemotherapy (yes/no: HR = 1.45, 95% CI: 0.46-4.63). Conclusions: This study demonstrated that abnormal LncRNAs expression might be potential prognostic markers to predict worse overall survival in osteosarcoma patients. However, the cut-off values may be the source of heterogeneity.
引用
收藏
页码:76 / 90
页数:15
相关论文
共 51 条
  • [1] Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872
  • [2] Bone Tumors in Adolescents and Young Adults
    Bielack, Stefan S.
    Carrle, Dorothe
    Hardes, Jendrik
    Schuck, Andreas
    Paulussen, Michael
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2008, 9 (01) : 67 - 80
  • [3] The IncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma
    Cai, Lijun
    Lv, Jinhan
    Zhang, Yinquan
    Li, Junhong
    Wang, Yinong
    Yang, Huilin
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (11) : 2654 - 2662
  • [4] Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription
    Chen, Fenyong
    Mo, Jiadong
    Zhang, Li
    [J]. TUMOR BIOLOGY, 2016, 37 (10) : 13403 - 13412
  • [5] Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis
    Chi, Shuqi
    Shen, Lina
    Hua, Teng
    Liu, Shuangge
    Zhuang, Guobing
    Wang, Xiaoxiao
    Zhou, Xing
    Wang, Guozhen
    Wang, Hongbo
    [J]. ONCOTARGET, 2017, 8 (45) : 79061 - 79072
  • [6] Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma
    Cong, Menglin
    Li, Jianmin
    Jing, Rui
    Li, Zhenzhong
    [J]. TUMOR BIOLOGY, 2016, 37 (07) : 9441 - 9450
  • [7] Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
    Duchman, Kyle R.
    Gao, Yubo
    Miller, Benjamin J.
    [J]. CANCER EPIDEMIOLOGY, 2015, 39 (04) : 593 - 599
  • [8] A systematic review of p53 as a biomarker of survival in patients with osteosarcoma
    Fu, Hai-Liang
    Shao, Lin
    Wang, Qiang
    Jia, Tao
    Li, Ming
    Yang, Da-Ping
    [J]. TUMOR BIOLOGY, 2013, 34 (06) : 3817 - 3821
  • [9] Gao KT, 2016, EUR REV MED PHARMACO, V20, P3561
  • [10] Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma
    Guo, Junyu
    Reddick, Wilburn E.
    Glass, John O.
    Ji, Qing
    Billups, Catherine A.
    Wu, Jianrong
    Hoffer, Fredric A.
    Kaste, Sue C.
    Jenkins, Jesse J.
    Ortega Flores, Ximena C.
    Quintana, Juan
    Villarroel, Milena
    Daw, Najat C.
    [J]. CANCER, 2012, 118 (15) : 3776 - 3785